Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Dabaja is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1999 - 2003
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 1999
Lebanese University School of MedicineClass of 1991
Certifications & Licensure
FL State Medical License 2021 - Present
TN State Medical License 2022 - 2028
TX State Medical License 2006 - 2027
WA State Medical License 2022 - 2027
AL State Medical License 2022 - 2026
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy Start of enrollment: 2009 Jun 01
- Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides Start of enrollment: 2010 Feb 01
- Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.Michael Oertel, Bouthaina Dabaja, Dennis Görlich, Bjorn R Thomas, Van Sim
Blood. 2026-06-18 - Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell Lymphoma.Savita V Dandapani, Sairah Ahmed, Timothy Robinson, Ranjana Advani, James Bates
International Journal of Radiation Oncology, Biology, Physics. 2026-03-03 - 1 citationsHodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.Ranjana H Advani, Christopher R Kelsey, Philippe Armand, Celeste M Bello, Cecil M Benitez
Journal of the National Comprehensive Cancer Network. 2026-02-01
Journal Articles
- Assessment of Radiation Doses Delivered to Organs at Risk Among Patients with Early-Stage Favorable Hodgkin Lymphoma Treated with Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, Jason Westin, Simrit Parmar, Loretta Nastoupil, Sattva Neelapu, Bouthaina S Dabaja, JAMA Network Open
Press Mentions
Low-Dose Radiation Effective With/Without Concurrent Chemotherapy in R/R Mantle Cell LymphomaSeptember 5th, 2019
Guidelines for Proton Therapy in Mediastinal LymphomasSeptember 19th, 2018
Family First After My Non-Hodgkin’s B-cell Lymphoma DiagnosisJanuary 17th, 2017
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Lymphoma, American College of Radiology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
